Evidence map›Paper›PMID 38655872›Full record

ArticleThe Journal of clinical endocrinology and metabolism2025

Inflammation-based Scores in Patients With Pheochromocytoma.

Chiara Parazzoli, Alessandro Prete, Vittoria Favero, Carmen Aresta, Valentina Pucino, John Ayuk, Miriam Asia, Yasir S Elhassan, Iacopo Chiodini, Cristina L Ronchi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Chiara ParazzoliDepartment of Biotechnology and Translational Medicine, University of Milan, 20100 Milan, Italy.ORCID 0000-0002-6789-3961
Alessandro PreteInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham B15 2TT, United Kingdom.ORCID 0000-0002-4821-0336
Vittoria FaveroDepartment of Biotechnology and Translational Medicine, University of Milan, 20100 Milan, Italy.
Carmen ArestaDepartment of Endocrine and Metabolic Diseases, IRCCS, Istituto Auxologico Italiano, 20100 Milan, Italy.
Valentina PucinoKennedy Institute of Rheumatology, University of Oxford, Oxford OX3 7FY, UK.ORCID 0000-0002-7683-4568
John AyukDepartment of Endocrinology, Queen Elizabeth Hospital Birmingham, Birmingham B15 2GW, UK.
Miriam AsiaDepartment of Endocrinology, Queen Elizabeth Hospital Birmingham, Birmingham B15 2GW, UK.
Yasir S ElhassanInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham B15 2TT, United Kingdom.
Iacopo ChiodiniDepartment of Biotechnology and Translational Medicine, University of Milan, 20100 Milan, Italy.ORCID 0000-0001-7594-3300
Cristina L RonchiInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham B15 2TT, United Kingdom.
Queen Elizabeth Hospital Birmingham · GBUniversity of Milan · ITIRCCS Istituto Auxologico Italiano · ITUniversity Hospitals Birmingham NHS Foundation Trust · GBUniversity of Oxford · GB

Funding

Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation TrustNational Institute for Health and Care ResearchUniversity of Birmingham NIHR203326
6 · The paper itself

Abstract

backgroundPheochromocytoma is associated with systemic inflammation but the underlying mechanisms are unclear. Therefore, we investigated the relationship between plasma metanephrine levels and hematological parameters-as a surrogate of inflammation-in patients with pheochromocytoma and the influence of preoperative α-blockade treatment. DESIGN AND

methodsWe retrospectively studied 68 patients with pheochromocytoma who underwent adrenalectomy (median age, 53 years; 64.7% females) and 2 control groups matched for age, sex, and body mass index: 68 patients with nonfunctioning adrenocortical tumors and 53 with essential hypertension. The complete blood count and several inflammation-based scores (neutrophil-to-lymphocyte ratio [NLR], platelet-to-lymphocyte ratio [PLR], lymphocyte-to-monocyte ratio [LMR], systemic-immune-inflammation index [SII], prognostic-nutrition index) were assessed in all patients and, in a subset of pheochromocytomas, after adrenalectomy (n = 26) and before and after preoperative α-blockade treatment (n = 29).

resultsA higher inflammatory state, as indicated by both complete blood count and inflammation-based scores, was observed in patients with pheochromocytoma compared with nonfunctioning adrenocortical tumors and essential hypertension. Plasma metanephrine levels showed a positive correlation with NLR (r = 0.4631), PLR (r = 0.3174), and SII (r = 0.3709) and a negative correlation with LMR (r = 0.4368) and prognostic-nutrition index (r = 0.3741), even after adjustment for age, sex, ethnicity, body mass index, and tumor size (except for PLR). After adrenalectomy, we observed a reduction in NLR (P = .001), PLR (P = .003), and SII (P = .004) and a concomitant increase in LMR (P = .0002). Similarly, α-blockade treatment led to a reduction in NLR (P = .007) and SII (P = .03).

conclusionInflammation-based scores in patients with pheochromocytoma showed pro-inflammatory changes that correlated with plasma metanephrine levels and are ameliorated by adrenalectomy and α-blockade.

Indexed as

Adrenal Gland NeoplasmsInflammationPheochromocytomaAdrenalectomyAdrenergic alpha-AntagonistsAdultAgedFemaleHumansMaleMetanephrineMiddle AgedNeutrophilsRetrospective StudiesAdrenergic alpha-AntagonistsMetanephrinealfa-blockadecatecholaminesinflammation scoresmetanephrinespheochromocytoma

Identifiers

PMID38655872
PMCPMC11834728
OpenAlexW4395064603

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.